Back
CASI Pharmaceuticals Stock Price Chart
Sponsored
CASI
Sponsored
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
18
CASI
CASI Pharmaceuticals
Last Price:
$2.65
Seasonality Move:
4.5%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASI is experiencing selling pressure, which indicates risk of future bearish movement.
CASI Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.96 | Sell |
20-day SMA: | 3.48 | Sell |
50-day SMA: | 4.82 | Sell |
200-day SMA: | 4.74 | Sell |
8-day EMA: | 2.97 | Sell |
20-day EMA: | 3.53 | Sell |
50-day EMA: | 4.46 | Sell |
200-day EMA: | 4.95 | Sell |
CASI Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.62 | Sell |
Relative Strength Index (14 RSI): | 29.16 | Sell |
Chaikin Money Flow: | -76852 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.93 - 4.79) | Sell |
Bollinger Bands (100): | (4.41 - 6.83) | Sell |
CASI Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for CASI Pharmaceuticals Stock
Is CASI Pharmaceuticals Stock a Buy?
-
CASI Pharmaceuticals share price is 2.65 while CASI 8-day simple moving average is 2.96, which is a Sell signal.
-
The stock price of CASI is 2.65 while CASI Pharmaceuticals 20-day SMA is 3.48, which makes it a Sell.
-
CASI Pharmaceuticals 50-day simple moving average is 4.82 while CASI share price is 2.65, making it a Sell technically.
-
CASI stock price is 2.65 and CASI Pharmaceuticals 200-day simple moving average is 4.74, creating a Sell signal.
CASI Technical Analysis vs Fundamental Analysis
Sell
18
CASI Pharmaceuticals (CASI)
is a Sell
Is CASI Pharmaceuticals a Buy or a Sell?
-
CASI Pharmaceuticals stock is rated a SellThe current CASI Pharmaceuticals [CASI] share price is $2.65. The Score for CASI is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
CASI Pharmaceuticals Stock Info
Market Cap:
41M
Price in USD:
2.65
Share Volume:
76.9K
CASI Pharmaceuticals 52-Week Range
52-Week High:
8.19
52-Week Low:
2.05
Sell
18
CASI Pharmaceuticals (CASI)
is a Sell
CASI Pharmaceuticals Share Price Forecast
-
What is the CASI Pharmaceuticals stock price today?The CASI Pharmaceuticals stock price is 2.65 USD today.
-
Will CASI stock go up or go down?CASI Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is CASI Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CASI Pharmaceuticals is overvalued.
Is CASI Pharmaceuticals Stock a Buy?
-
CASI Pharmaceuticals share price is 2.65 while CASI 8-day exponential moving average is 2.97, which is a Sell signal.
-
The stock price of CASI is 2.65 while CASI Pharmaceuticals 20-day EMA is 3.53, which makes it a Sell.
-
CASI Pharmaceuticals 50-day exponential moving average is 4.46 while CASI share price is 2.65, making it a Sell technically.
-
CASI stock price is 2.65 and CASI Pharmaceuticals 200-day simple moving average is 4.95, creating a Sell signal.
Fundamental Analysis of CASI Pharmaceuticals
Is CASI Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.
Technical Analysis of CASI Pharmaceuticals
Should I short CASI Pharmaceuticals stock?
-
CASI Moving Average Covergence Divergence (MACD) indicator is -0.62, suggesting CASI Pharmaceuticals is a Sell
-
CASI Pharmaceuticals Relative Strength Index (RSI) is 29.16, which suggest CASI Pharmaceuticals is oversold
-
The Bollinger Bands (25) for CASI Pharmaceuticals is (2.93 - 4.79), which suggest CASI Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for CASI Pharmaceuticals is (4.41 - 6.83), which suggest CASI Pharmaceuticals is a Sell
* CASI Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.